Rare Tumours SACT regimens:

Whilst every effort is made to ensure the accuracy of the information in a given regimen it cannot be guaranteed that the regimen is fully up to date, because of the dynamic nature of cancer treatment. Check the regimen details for the specific indication the regimen may be used / funded in. See our disclaimer.

Adrenal

• Doxorubicin Cisplatin Etoposide (EDP)
• Mitotane

Carcinoid

• Capecitabine (1000) 

Neuroendocrine

• Capecitabine (1000)
• Carboplatin Etoposide
• Cisplatin Etoposide
• Everolimus (Blueteq registration no longer required)
• Irinotecan Modified de Gramont (FolFIri) (local funding)
• Steptozocin Capecitabine
• Streptozocin Cisplatin Fluorouracil (FCiST)
• Steptozocin Modified de Gramont
• Sunitinib
• Temozolomide Capecitabine

Parathyroid

• Fluorouracil Cyclophosphamide Dacarbazine

Penile

• Cisplatin Methotrexate Bleomycin (PMB)
• Paclitaxel Ifosfamide Cisplatin (TIP) 3 day – draft regimen

Thymoma

• Cisplatin Etoposide
• Cyclophosphamide Vincristine Dacarbazine (CVD)
• Doxorubicin Cisplatin Cyclophosphamide (CAP)
• Doxorubicin Cisplatin Vincristine Cyclophosphamide (ADOC)

Thyroid

• Cabozantinib
• Dabrafenib Trametinib
• Lenvatinib
• Selpercatinib 
• Sorafenib

von Hippel-Lindau (VHL)

• Belzutifan

Carcinoma of unknown primary (CUP)

• Carcinoma of unknown primary chemotherapy options

Cisplatin hydration

• Cisplatin hydration

SACT regimens written by S Coutts

For further information please contact us using our contact us page.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.